Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Goupille

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Arthritis Research & Therapy|October 30, 2016
Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentMatthieu Lavielle, Denis Mulleman, Philippe Goupille, et al.
Rheumatology (Oxford, England)|March 18, 2019
Measuring spinal mobility in early axial spondyloarthritis: does it matter?Mary Lucy Marques, Sofia Ramiro, Philippe Goupille, et al.
The Journal of Rheumatology|July 17, 2014
Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohortGaël Mouterde, Cédric Lukas, Philippe Goupille, et al.
British Journal of Clinical Pharmacology|June 23, 2011
Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitisDavid Ternant, Denis Mulleman, Francine Lauféron, et al.
Rheumatology (Oxford, England)|September 17, 2014
Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohortLudovic Bacconnier, Nathalie Rincheval, René-Marc Flipo, et al.
Arthritis Research & Therapy|September 6, 2008
Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective studyNatacha Courvoisier, Maxime Dougados, Alain Cantagrel, et al.
Therapeutic Drug Monitoring|April 22, 2006
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximabDavid Ternant, Denis Mulleman, Danielle Degenne, et al.
Arthritis Research & Therapy|November 27, 2009
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritisDenis Mulleman, Jean-Camille Méric, Gilles Paintaud, et al.
Joint Bone Spine|June 9, 2016
Comparison of the Big Five personality traits in fibromyalgia and other rheumatic diseasesEmilie Bucourt, Virginie Martaillé, Denis Mulleman, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE studyRené-Marc Flipo, Florence Tubach, Philippe Goupille, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Arthritis Research & Therapy|October 30, 2016
Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentMatthieu Lavielle, Denis Mulleman, Philippe Goupille, et al.
Rheumatology (Oxford, England)|March 18, 2019
Measuring spinal mobility in early axial spondyloarthritis: does it matter?Mary Lucy Marques, Sofia Ramiro, Philippe Goupille, et al.
The Journal of Rheumatology|July 17, 2014
Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohortGaël Mouterde, Cédric Lukas, Philippe Goupille, et al.
British Journal of Clinical Pharmacology|June 23, 2011
Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitisDavid Ternant, Denis Mulleman, Francine Lauféron, et al.
Rheumatology (Oxford, England)|September 17, 2014
Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohortLudovic Bacconnier, Nathalie Rincheval, René-Marc Flipo, et al.
Arthritis Research & Therapy|September 6, 2008
Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective studyNatacha Courvoisier, Maxime Dougados, Alain Cantagrel, et al.
Therapeutic Drug Monitoring|April 22, 2006
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximabDavid Ternant, Denis Mulleman, Danielle Degenne, et al.
Arthritis Research & Therapy|November 27, 2009
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritisDenis Mulleman, Jean-Camille Méric, Gilles Paintaud, et al.
Joint Bone Spine|June 9, 2016
Comparison of the Big Five personality traits in fibromyalgia and other rheumatic diseasesEmilie Bucourt, Virginie Martaillé, Denis Mulleman, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE studyRené-Marc Flipo, Florence Tubach, Philippe Goupille, et al.
Pageof 13